ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank57
3Y CAGR+47.8%
5Y CAGR+13.6%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+47.8%/yr
vs -30.7%/yr prior
5Y CAGR
+13.6%/yr
Recent acceleration
Acceleration
+78.5pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 25.55% | +148.7% |
| 2024 | 10.27% | -53.1% |
| 2023 | 21.90% | +176.7% |
| 2022 | 7.91% | +449.0% |
| 2021 | 1.44% | -89.3% |
| 2020 | 13.49% | -54.1% |
| 2019 | 29.40% | -14.2% |
| 2018 | 34.28% | +6.1% |
| 2017 | 32.32% | -26.2% |
| 2016 | 43.78% | - |